PRSS23 抗体 (AA 20-383)
Quick Overview for PRSS23 抗体 (AA 20-383) (ABIN7625490)
抗原
See all PRSS23 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 20-383
- 
                                            原理
- Protease, Serine 23 (PRSS23) Polyclonal Antibody
- 
                                            序列
- Gln20~Gly383
- 
                                            产品特性
- The Protease, Serine 23 (PRSS23) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
- 
                                            纯化方法
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- 0.5 mg/mL
- 
                                            缓冲液
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            储存方法
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - PRSS23 (Protease, Serine, 23 (PRSS23))
- 
                                            别名
- PRSS23
- 
                                            基因ID
- 11098
- 
                                            UniProt
- O95084
 抗原
- 
                    
 
                                     
                                     
                                    